Applied DNA (APDN) EV/EBITDA Multiple
Applied DNA Sciences (APDN) is a recognized global authority in molecular verification, having earned high trust from government agencies and textile behemoths. The business relies on the production of linear DNA strands for medicine and logistics security, which mitigates the risks of narrow-niche crises. The market trend visualized in monetary format on GURU.Markets, where the indicator stands at , demonstrates the impact of excess capacity following the decline in demand for PCR diagnostics.
adnas.com - analytical breakdowns and key metrics (APDN)
- current price and projected stock value:
- market capitalization details:
- issuer book value statistics:
- debt and liquidity data:
Total Debt to Capital Applied DNA Sciences|APDN - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Applied DNA Sciences, Inc.|APDN - Company Aggregate Debt|Debts to Book Capitalization Applied DNA Corp|APDN - Company Long-Term Debts|Company Current Liabilities Applied DNA Sciences|Quick Liquidity adnas.com
- financial results and valuation multiples details:
APDN - Net Financial Result|Projected Future Earnings Applied DNA Sciences|APDN - Price to Earnings Ratio|Forward P/E Multiple Applied DNA Sciences|APDN - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Applied DNA Corp|APDN - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Applied DNA Sciences|APDN - Earnings per share for the last 12 months|Quarterly EPS earnings growth adnas.com|APDN - Net earnings per share growth this year|Earnings growth forecast for next year Applied DNA Sciences
Fundamental company valuation:Applied DNA APDN
Applied DNA Sciences maintains technological leadership in ultra-pure DNA synthesis via LinearDNA, which requires significant capital expenditures. By analyzing the EV/EBITDA chart against historical data, we assess the enterprise value relative to operating profit before interest, taxes, depreciation, and amortization. The current value of helps determine how effectively the company monetizes its patents, separating fundamental growth from market noise.
Competitors of Applied DNA Sciences
EV/EBITDA Multiple TEM (tempus.com)|Total Company Value to Operating Income Before Depreciation Ratio Qiagen Corp (QGEN)|Ionis Pharmaceuticals - EV/EBITDA Multiple|Company Value to EBITDA repligen.com|RNA: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation CRSP|Enterprise Value to EBITDA Ratio WGS|RARE: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple BEAM|sarepta.com - Enterprise Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Twist Bioscience, Inc. TWST|TXG: Enterprise Value to Operating Income Before Depreciation|Intellia - EV/EBITDA Multiple|STOK - EV/EBITDA Multiple|BLFS (BioLife Solutions, Inc.) - Enterprise Value to EBITDA Ratio|wavelifesciences.com - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Maze Therapeutics|Sionna Therapeutics, Inc. (SION) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple PRME|Enterprise Value to EBITDA Ratio Taysha Corp TSHA|EV/EBITDA Multiple QURE (uniQure N.V.)|Total Company Value to Operating Income Before Depreciation Ratio meiragtx.com (MGTX)|REGENXBIO - EV/EBITDA Multiple|Company Value to EBITDA Solid Biosciences Inc|Ocugen Corp (OCGN) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation PACB|BNTC (Benitec Biopharma Inc.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio designtx.com (DSGN)|EV/EBITDA Multiple RCKT|FDMT - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Lexeo Therapeutics, Inc. LXEO|Total Company Value to Operating Income Before Depreciation Ratio Korro Bio Inc. (KRRO)|Editas Medicine, Inc. - EV/EBITDA Multiple|SLN - EV/EBITDA Multiple|proqr.com (PRQR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio CDXS (Codexis)|SGMO (Sangamo) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation NAUT (Nautilus Biotechnology Inc)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Metagenomi, Inc. (MGX)|precisionbiosciences.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple GBIO (Generation Bio)|BOLD: Enterprise Value to Operating Income Before Depreciation|XCUR - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|IMNN (Imunon, Inc.) - Enterprise Value to Operating Income Before Depreciation|PHIO: EV/EBITDA Multiple|Mustang Bio (MBIO) - EV/EBITDA Multiple|RNAZ (TransCode Therapeutics Inc.) - EV/EBITDA Multiple|EV/EBITDA Multiple Bionano|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bluebird Bio (BLUE)|IPA: Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Omega Therapeutics OMGA|OMIC (singulargenomics.com) - Company Value to Operating Income Before Depreciation Ratio|RGLS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SYRS: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TBIO: EV/EBITDA Multiple|TCON - Total Company Value to Operating Income Before Depreciation Ratio|UBX (Unity Biotechnology) - EV/EBITDA Multiple
